Beekley Medical 0-SPOT Mammography Skin Markers REF 652
FDA Device Recall #Z-2309-2017 — Class III — May 8, 2017
Recall Summary
| Recall Number | Z-2309-2017 |
| Classification | Class III — Low risk |
| Date Initiated | May 8, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Beekley Corporation |
| Location | Bristol, CT |
| Product Type | Devices |
| Quantity | 104 boxes (58/box)= 6,032 total units |
Product Description
Beekley Medical 0-SPOT Mammography Skin Markers REF 652
Reason for Recall
Mammography Skin Marker 0 -SPOT (REF 652) product was mis-labeled with A-SPOT (REF 651) labels
Distribution Pattern
US Distribution to the states of : AR, CA GA, IL, TX, MN, NV, NY, WI., and Internationally to Canada.
Lot / Code Information
LOT 652.04251701
Other Recalls from Beekley Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2831-2018 | Class II | S-SPOT REF 777, 777S Adhere to skin for mar... | Jun 13, 2018 |
| Z-2832-2018 | Class II | TomoSPOT REF 782, 782S, 783, 783S, 784, 784S, 7... | Jun 13, 2018 |
| Z-2830-2018 | Class II | O-SPOT REF 791, 791S Adhere to skin for mar... | Jun 13, 2018 |
| Z-1787-2014 | Class III | Beekley Spots Light Image O-Spots for Mammograp... | Jun 19, 2013 |
| Z-2112-2012 | Class II | Beekley Altus Floral Skin Markers -Order Number... | Jul 9, 2012 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.